Recent Quotes
My Watchlist
Indicators
Local Stocks
NewsOK Local Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Harmony Biosciences Holdings Inc (NQ: HRMY )

50.48 -0.13 (-0.26%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 29, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 359,452
Open 51.64
Bid (Size) 47.24 (1)
Ask (Size) 53.75 (1)
Prev. Close 50.61
Today's Range 49.75 - 52.47
52wk Range 25.09 - 54.00
Shares Outstanding 59,048,228
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Corcept Stock Near Buy Point; Strength Rating Jumps To 91
The new 91 RS Rating means that Corcept stock has outperformed 90% of all other stocks over the past year. 
Via Investor's Business Daily
7 No-Brainer Biotech Stocks to Add to Your Buy List
With the broader markets grumbling, investors should consider biotech stocks to buy for their permanently relevant profile. 
Via InvestorPlace

Performance

YTD
+12.70%
+12.70%
1 Month
+15.78%
+15.78%
3 Month
+0.58%
+0.58%
6 Month
+17.48%
+17.48%
1 Year
+72.35%
+72.35%

More News

Read More
80 Biggest Movers From Yesterday
Via Benzinga
Harmony Biosciences: Q1 Earnings Insights
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Harmony Biosciences Q1 2022 Earnings Conference Call On May 3, 2022 At 08:30 AM ET
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 14, 2022
Via Benzinga
24 Biggest Movers From Yesterday
Via Benzinga
Bristol Myers, Eli Lilly And 2 Others Prove You Can Still Make Money In Medical Stocks
Via Investor's Business Daily
Harmony Biosciences: Q4 Earnings Insights
Via Benzinga
3 Desirable Drug Stocks With Very Promising Pipelines
Via InvestorPlace
Top Buzzing Stocks For 2022
Via Talk Markets
Datadog, Applied Materials Lead Five Stocks Near Buy Points For The New Year
Via Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For December 1, 2021
Via Benzinga
Harmony Biosciences Holdings, Inc. (HRMY) Q3 2021 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Benzinga's Top Ratings Upgrades, Downgrades For November 4, 2021
Via Benzinga
Leading the Charge to Develop the First Orexin-Targeted Therapy to Address Narcolepsy at its Root Cause
Via Benzinga
Mid-Afternoon Market Update: Dow Surges Over 100 Points; Harmony Biosciences Shares Spike Higher
Via Benzinga
Topics Stocks
Exposures US Equities
52 Biggest Movers From Yesterday
Via Benzinga
Why Harmony Biosciences Stock Is Up 15% Today
Via The Motley Fool
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Mid-Day Market Update: Silver Surges 3%; Galera Therapeutics Shares Plunge
Via Benzinga
Topics Stocks
Exposures US Equities
Mid-Morning Market Update: Markets Open Higher; Johnson & Johnson Boosts FY21 Guidance
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 23, 2021
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.